KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Assets (2016 - 2026)

Merck has reported Assets over the past 18 years, most recently at $128.7 billion for Q1 2026.

  • Quarterly Assets rose 11.78% to $128.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $128.7 billion through Mar 2026, up 11.78% year-over-year, with the annual reading at $136.9 billion for FY2025, 16.87% up from the prior year.
  • Assets was $128.7 billion for Q1 2026 at Merck, down from $136.9 billion in the prior quarter.
  • Over five years, Assets peaked at $136.9 billion in Q4 2025 and troughed at $104.5 billion in Q2 2023.
  • The 5-year median for Assets is $109.2 billion (2022), against an average of $113.9 billion.
  • Year-over-year, Assets increased 18.09% in 2022 and then dropped 2.45% in 2023.
  • A 5-year view of Assets shows it stood at $109.2 billion in 2022, then dropped by 2.28% to $106.7 billion in 2023, then grew by 9.78% to $117.1 billion in 2024, then grew by 16.87% to $136.9 billion in 2025, then decreased by 5.98% to $128.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Assets are $128.7 billion (Q1 2026), $136.9 billion (Q4 2025), and $129.5 billion (Q3 2025).